活动概览 | 晶云药物与您相约十月
2024-10-09

2024年10月,苏州晶云药物科技股份有限公司(以下简称“晶云药物”)即将参与一系列重要的线下行业活动,我们诚挚地邀请您与我们一同相聚苏州、San Francisco、San Diego以及Salt Lake City,共同探讨行业前沿,分享创新技术。


行业会议

01

SAPA-China 2024

医药产业大会

10/18-19 | 苏州

QQ截图20241009164007



“SAPA-China 2024医药产业大会-弘扬创新合作,加快产业融合”将于2024年10月18-19日在苏州·狮山国际会议中心举办。届时将有7000余位来自全球顶尖科研机构的学者以及大型跨国制药及生物技术创新企业领军人物等参会,大会围绕大/小分子、细胞基因治疗、AI制药、核酸GLP-1与代谢、临床、核素偶联药物、出海合作、投融资等热点领域主题,举办高层论坛专题论坛、项目对接、融资推介、企业展示等系列活动。


时间:2024年10月18-19日

地点:苏州狮山国际会议中心

展位:A23


QQ截图20241009164015



海外活动

02

The 16th Drug Discovery Strategic Summit (DDSS) - San Francisco

10/9-10 PDT | San Francisco, CA

QQ截图20241009164022


Date: October 9-10, 2024

Location: San Francisco Airport Marriott Waterfront

Booth: 3

Attendee: Robert Wenslow, Ph.D. (Speaker) & Ridwan Islam, Ph.D.


Presentation title:

“The Best Use of 10 mg” - Achieve CMC Success through a Unique Optimization of Compound Benchwork and Computational Analysis


Abstract: Small Molecule drug discovery scientists have been trained to believe that they need gram scale quantities of API to determine CMC properties such as solubility, oral absorption, and salt selection to understand the formulation strategy. Crystal Pharmatech will unveil its proven approach to understanding the developmental risks through focused laboratory work and the most advanced computational approaches. You will understand how, with only 10 mg of material, you can move from late lead-op to FIH with a line-of-sight of your compound’s development path and significantly enhance your probability of success in the clinic.


Link: https://ddsswc.agilefalconsg.com/event-guide/



03

Formulation & Delivery US 2024

10/16-17 PDT | San Diego, CA

QQ截图20241009164029


Date: October 16-17, 2024

Location: DoubleTree by Hilton Hotel San Diego - Mission Valley

Booth: 12

Attendee: Jessica (Xiaoxia) Chen, Ph.D. (Speaker) & Decheng Ma, Ph.D.


Presentation title:

First in Human (FIH) Tablet Development for an Amorphous Unstable Prodrug with Enteric Coating Using an API Sparing Approach


Abstract: This presentation will explore the formulation and development process of First-In-Human (FIH) enteric-coated tablets at three dose strengths for an amorphous prodrug highly susceptible to hydrolysis under both acidic and basic conditions. We will delve into the scientific approaches employed to mitigate degradation pathways, ensure product stability through carefully selected excipients and optimized manufacturing techniques, and how material science-based approaches can lead to successful FIH product development within tight timelines.


QQ截图20241009164037



Link: https://oxfordglobal.com/discovery-development/events/formulation-delivery-us-2024



04


AAPS 2024 PHarmSCi 360

10/20-23 MDT | Salt Lake City, UT

QQ截图20241009164042


Meet with industry leadership to discuss:

  • Developability Assessment

  • API Form and Solid-State Research

  • Formulation Development

  • Clinical and Commercial Manufacturing

  • Biologics Analytical Services


Date: October 20-23, 2024

Location: Salt Palace Convention Center, Salt Lake City, UT

Attendee: Alex Chen, Ph.D. & Robert Wenslow, Ph.D. & Decheng Ma, Ph.D. & Ridwan Islam, Ph.D.

Booth: 3139


QQ截图20241009164056


Link: https://www.aaps.org/pharmsci/annual-meeting



原文请点击查阅

在线留言

*
*
*
*
*